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1. Introduction 
There are at least three perspectives from which one can think about using risk prediction 
and outcomes data in cardiothoracic surgery. The first is the perspective of the patient in 
need of cardiothoracic surgery procedure and care, who wishes to know, “What are my 
chances?” An engaged patient and family are interested in the patient’s survival of the acute 
condition or event, but also interested in the near- and long-term outlook and quality of life 
beyond the recovery period. 
The second is the perspective of the surgeon, wishing to know, “How am I doing?” This is 
the essence of the general competency in medical education known as practice-based 
learning and improvement, which entails review of and reflection on one’s practice patterns 
and using this self-assessment to improve one’s practice, particularly assessing against 
standards of care and specialty practice guidelines. Moreover, it can be argued that as health 
care is a team sport, rather than a solo act, that perspective should be expanded to reflect the 
whole interdisciplinary team asking, “How are we doing?” 
Finally, the societal perspective—including regulators and payers—seeks information that 
answers whether or not we are delivering care that is safest and of highest quality for the 
cost and the resources invested. 
The Institute of Medicine in To Err is Human articulates six key parameters by which quality 
of care is assessed and which are important to all three perspectives, with those parameters 
being for care that is safe, timely, effective, efficient, equitable and patient-centered [1]. As 
decisions are made and care is delivered for each patient as an individual case, the 
practitioner makes what he or she believes to be the best decisions for care based on the 
individual patient characteristics and needs and the information available at the time. 
However, it is the decision-making and care delivery trends that are highly informative to all 
three perspectives described above.  
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This chapter focuses on the following areas of risk and outcome data use: 1) clinical 
cardiothoracic databases; 2) risk factors and risk prediction models; 3) application of risk 
prediction in clinical decision-making and care delivery; 4) process and outcomes data for 
reporting and improvement; and 5) use of database linkages to determine factors and 
decisions contributing to outcomes across the continuum of care. 
2. Cardiothoracic databases 
Surgeons have been interested in monitoring and improving outcomes since Ernest Amory 
Codman pioneered the study of medical outcomes. He kept “end result cards” on his 
patients, including long-term outcomes of at least one year, and wrote several papers on the 
“end result idea” in the early 1900s [2]. The ability to speak knowledgably about risk 
assessment and clinical outcomes for any clinical specialty requires data gathered on the 
patients treated by that specialty—whether based on diagnostic category, acute event or 
performance of a particular procedure or set of procedures. This is of even greater value 
when one can speak about one’s own patient population and performance data, using data 
that are complete and valid and analyzed in comparison to a large number of patients of 
comparable condition. 
2.1. Administrative databases  
Administrative data, such as the data from the Centers for Medicare and Medicaid Services 
database, are readily available, relatively inexpensive, and provide information on large 
numbers of patients. However, administrative data are usually collected by coding for 
billing purposes rather than collection for clinical studies and improvement, so that critical 
clinical context and variables are unavailable and the differentiation of comorbidities from 
complications can be problematic [3,4].  
The University HealthSystem Consortium (UHC) is an alliance if 101 academic medical 
centers and nearly 200 of their affiliate hospitals—representing more than 90% of the US 
nonprofit academic medical centers—which has developed risk-adjusted mortality models 
based on discharge abstracts and include adjustments for differences in patient severity 
using the All Patient Refined Diagnosis Related Groups (APR-DRG). The UHC refers to its 
data and risk model as clinical (versus administrative), because the data are derived from 
coding of clinical conditions. However, it should be noted that the source of the data sent to 
UHC by hospitals and healthcare systems is the financial and administrative data from the 
system, and therefore dependent on coding and demographic information, and drawn from 
the same data source used to report patient billing data to Medicare and other payers [5]. 
2.2. Clinical databases 
There are numerous notable clinical registries and databases for cardiothoracic surgery 
patients. Local and regional databases are particularly noteworthy for their ability to draw 
data from physician groups and hospitals that are traditionally competitive relative to one 
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another, but who agree to contribute data to build valid assessment of quality in cardiac 
care. Regional databases of note include those of the Northern New England Cardiovascular 
Disease Study Group (NNE) [6,7]. The New York State Department of Health has been 
building databases for reporting on adult cardiac surgery and percutaneous coronary 
interventions since the early 1990s, and subsequently added pediatric congenital cardiac 
surgery [8,9,10]. The Pennsylvania Health Care Cost Containment Council has databases 
that include hip and knee replacement, diabetes and health-associated infections, besides 
cardiac care [11]. Other states have followed, with a statewide approach to quality, such as 
the State of New Jersey Department of Health and Senior Services Office of Health Care 
Quality Assessment [12], the Minnesota Cardiac Surgery Database [13], the Michigan 
Society of Thoracic and Cardiovascular Surgeons Quality Collaborative [14], and the 
Virginia Cardiac Surgery Quality Initiative [15].  
The Veterans Affairs (VA) Cardiac Surgery Database [16,17] has been a leading force in 
national cardiac databases. The Department of Veterans Affairs has built on the experience 
in cardiac surgery to develop a database for major surgery outcomes and quality of care, as 
seen in the National VA Surgical Quality Improvement Program (NSQIP) database [18]. 
NSQIP has proven so valuable as to now be applied to surgery programs across the country, 
well beyond the VA medical centers.  
 The predominant national adult cardiac database in the US, beyond the VA, is the Society of 
Thoracic Surgeons (STS) National Cardiac Database (NCD) [19,20,21]. Building on the 
experience with the adult cardiac surgery database, the STS now has three components to 
the STS National Database—Adult Cardiac, General Thoracic Surgery Database, and 
Congenital Heart Surgery, with availability of anesthesiology participation in addition to 
surgeon participation in the Congenital Heart Surgery Database. The STS Congenital Heart 
Surgery Database has worked collaboratively at the international level on a joint European 
Association for Cardiothoracic Surgery (EACTS)-STS Congenital Database Committee, 
particularly on standardization of definitions and naming conventions [22,23,24]. Moreover, 
the World Society for Pediatric and Congenital Heart Surgery has gathered surgeons from 
over 50 countries and from all continents except Antarctica to work on pediatric cardiology 
and pediatric cardiac surgery [25,26,27]. 
In addition to EACTS, other international registry endeavors in cardiothoracic surgery 
include the Society for Cardiothoracic Surgery in Great Britain and Ireland [28], the 
Australian and New Zealand Society of Cardiac and Thoracic Surgeons Database [29], the 
Japan Cardiovascular Surgery Database Organization [30], and the Chinese coronary 
artery bypass grafting (CABG) registry [31]. While there are numerous country and 
international region registries, the STS also now provides the opportunity for 
international participants to contribute to the Adult Cardiac Surgery Database. The 
awareness of need for process and outcome data for reporting and improvement has 
caught fire and driven endeavors around the world. Next, this chapter will explore how 
the data is analyzed and utilized. 
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3. Risk prediction—Assessing risk 
When outcomes and performance results are first brought up, it seems to be an almost 
reflexive defense response to say, “My patients are sicker.” Thus, it is the risk-adjusted 
outcomes that essentially level the playing field, comparing like with like to as close a 
degree as possible. It is therefore of great importance to gather information that is both 
clinically relevant and comprehensive, to get as complete a picture as possible of the patient 
factors, over which the surgeon has little control, as well as aspects that can impact both 
decision-making, care delivery and outcomes of that care.  
Further upstream in the continuum of care, a cardiothoracic surgeon depends on clinical 
judgment to assess the patient’s cardiac condition in the context of his/her general health, 
and then to determine whether there is technically something to offer the patient to improve 
that cardiac condition. Beyond the ability to do something for the patient, there then follows 
the consideration of whether surgical intervention is appropriate, given the patient’s 
condition, circumstances and preferences, and when. This is where there is great utility in 
having access to a reliable, easy-to-use risk prediction scoring system and tool. Granton and 
Cheng [32] have gathered information describing several of the predictive scoring systems 
available: the EuroSCORE [33,34], the STS score, the Parsonnet score [35,36], and regional 
models such as the Cleveland Clinic model and the NNE score. Additionally, the 
AusSCORE [37] has been developed and studied for Australian patients. 
A core set of variables associated with outcomes in cardiothoracic surgery have evolved 
over time. Accuracy of risk models developed based on administrative data in New York 
[10] and Pennsylvania [11] have been shown to be substantially improved by addition of a 
few critical clinical variables—ejection fraction, reoperation, and left main coronary artery 
obstruction. One may further question how many variables are actually needed to have a 
robust risk prediction model. Studies from Ontario [38] and the Cooperative CABG Database 
Project [39] identified six and seven core variables, respectively. In the STS NCD, it has been 
demonstrated that 78% of the explained variance from the 28-variable model is derived from 
the eight most important predictors, which are age, surgical acuity, reoperative status, 
creatinine level, dialysis, shock, chronic lung disease, and ejection fraction [40]. 
While there are minor variations between the data collection forms for the various 
databases, the primary differences are derived from the correlation coefficients for the risk 
factors as calculated from the different patient populations. For purposes of description of 
data collection, the STS National Databases—Adult Cardiac Surgery [41], General Thoracic 
Surgery [42], and Congenital Heart Surgery [43]—are used in the section that follows. 
3.1. Risk factors 
Preoperative risk factors. Preoperative risk factors that are collected relate primarily to the 
presenting features of the patient. These start with such factors as age, gender, race and 
ethnicity. Also collected are general resource factors such as referral pattern information via 
patient zip code and hospital zip code, and the payer type.  
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The next section after demographic information contains fields for admission, surgery and 
discharge dates, as well as hours of intensive care unit (ICU) stay. The general health factors 
are captured by fields for height, weight, smoking status, family history for heart disease, 
hematocrit, and white blood cell count. The comorbidities recorded include the presence or 
absence of the following: diabetes, dyslipidemia, renal failure requiring dialysis, 
hypertension, infectious endocarditis, chronic lung disease, immunosuppressive therapy, 
peripheral arterial disease, cerebrovascular disease and the form and timing of its effect. In 
addition, the current renal function is logged as the last creatinine, and for diabetics, the 
method of diabetes control.  
The cardiac presentation section contains fields for the following: previous myocardial 
infarction and time interval, heart failure, NYHA classification, cardiac presentation on 
admission, cardiogenic shock, resuscitation, arrhythmia and type, and previous 
cardiovascular interventions. Preoperative medications are recorded as yes, no or 
contraindicated/not indicated. Preoperative hemodynamics and catheterization and 
echocardiographic information are also recorded.  
The preoperative risk factors for general thoracic surgery include weight loss over prior 
three months, steroids, preoperative chemotherapy, pulmonary function tests and results, 
Zubrod (activity tolerance) score, and clinical staging for lung and esophageal cancer.  
For the congenital database, there is the additional information required on date of birth, 
prematurity, non-cardiac anatomic abnormalities, chromosomal abnormalities and 
congenital syndromes. The resuscitative preoperative factors captured for the congenital 
heart surgery patient include cardiopulmonary resuscitation, mechanical circulatory 
support, and shock. Metabolic risk factors include diabetes mellitus, hypothyroidism, and 
steroid requirement. Gastrointestinal risk factors relate to presence of colostomy, 
enterostomy, gastrostomy or esophagostomy, as well as hepatic dysfunction, or necrotizing 
entero-colitis. Neurological risk factors include neurological deficit, seizures, and stroke or 
intracranial hemorrhage. Respiratory risk factors include mechanical ventilation, respiratory 
syncytial virus, single lung, and trachesotomy. Additional factors captured include: 
coagulation disorder, endocarditis, sepsis, and renal dysfunction. 
For congenital heart surgery, there is an additional aspect of risk-adjustment that has been 
employed and tested. The Risk Adjustment for Congenital Heart Surgery-1 (RACHS-1) was 
developed by Dr. Kathy Jenkins and investigators from Children’s Hospital Boston [44]. The 
RACHS-1 goal was to adjust for baseline differences in case-mix and risk when comparing 
mortality prior to discharge from the hospital among patients under 18 years of age 
undergoing surgery for congenital cardiac disease or defect. It is important to note that the 
RACHS-1 was not created to predict the risk of death for individual patients, but to be a tool 
that allows meaningful comparisons across groups of patients [44]. 
It is worth noting that the available databases do not account for nutritional state, especially 
for malnourished patients. This is an aspect of general health that significantly impacts 
wound healing ability and immune system capacity to fight infectious complications. 
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Cardiac databases do not capture rehabilitation potential, as would be captured by a 
preoperative activity level and a realistic activity goal following recovery. For patients with 
a severely limited preoperative functional level, it would generally be unrealistic to expect a 
normal rate of separation from mechanical ventilation or length of stay. This also speaks to 
the level of postoperative recovery support required once the patient can be discharged 
from the hospital. Homelessness or severely limited social network support is also not 
captured by available databases. While these aspects of patient condition may not 
negatively impact the ability to heal and recover from a surgical procedure, they do affect 
the healthcare resources needed to achieve recovery, both in the hospital and following 
discharge. 
Perioperative risk factors. All of the procedural databases include surgeon identification, 
diagnosis, primary and secondary procedures, operative start and end dates and times 
(including operating room entry and exit, anesthesia start and end, and skin incision start 
and stop), antibiotic selection and timing for administration and discontinuation. Operation 
status—elective, urgent, emergent/salvage, or palliative is recorded. Blood product 
administration is also captured. 
Cardiopulmonary bypass utilization and associated features are recorded, including use of 
circulatory arrest, aortic occlusion, cardioplegia, and cerebral oximetry. Medication 
administration and use of intra-aortic balloon pump support are also captured. For coronary 
artery bypass surgery, the number of anastomoses is recorded for each type of conduit. 
Valve surgery procedures are captured, by valve, for type of procedure and prosthesis type 
utilized. Initial extubation date and time is captured to reflect the interval of intubation and 
ventilator support. 
The general thoracic surgery perioperative data also include pathologic staging for cancer 
and ICU length of stay. The congenital heart surgery data also include capture of procedure 
location, temperature, cerebral perfusion and oximetry utilized. In addition, pediatric 
cardiac surgeons have found it important to address the issue of stratification of complexity 
in surgery for congenital cardiac diseases. The Aristotle Complexity Score was developed by 
an expert panel, and consists of assignment of an Aristotle Basic Complexity score to a given 
procedure based on potential for mortality, potential for morbidity, and technical difficulty 
[44].  
Postoperative data collected. Postoperative transfusion and complications are collected for 
the databases. The complications are reflected by category: reoperation and reason, cardiac, 
neurologic, renal, pulmonary, infectious, vascular and other (gastrointestinal, urologic, 
hematologic). The discharge status, interval after surgery, and destination are key 
components, as well as the discharge medications. If readmission is necessitated, the reason 
is recorded. Key quality measures are captured for each of the databases.  
The congenital heart surgery collection forms include sections for gathering key information 
for anesthesiology participation in the database—preoperative assessment, anesthetic 
technique, monitoring, intraoperative and postoperative pharmacology, and anesthesia 
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adverse events. As there are a growing number of patients surviving their congenital heart 
defects to reach adulthood, the congenital heart surgery database also includes sections for 
adult cardiac surgery data components. 
3.2. Risk models 
Ivanov and colleagues studied the predictive accuracy of a statistical model against 
clinicians’ estimates of outcomes after coronary bypass surgery [45]. They found that 
clinicians, when given the option, preferred to trust their own judgments. Experienced 
surgeons significantly overestimated the risk of operative mortality compared to their junior 
colleagues. Overall, the clinicians significantly overestimated the probability of operative 
mortality (for survivors to a greater degree than non-survivors) and ICU stay greater than 48 
hours. Although no predictive model can predict the specific individual who will have an 
adverse event, statistical models permit reasonably accurate estimates of event rates for 
subgroups of patients [45]. 
The risk factors gathered by the database collection form for each patient are entered into 
the database, and aggregated for analysis and reporting. This can be accomplished by the 
individual surgeon or group with paper and pencil or an Excel spreadsheet. However, most 
clinicians are interested in risk-adjusted analysis of performance and outcomes to account 
for the particular characteristics of the patients and patient population to which care is 
rendered. Kozower and colleagues described their head-to-head comparison of the ability to 
predict risk-adjusted mortality by UHC and STS risk models [5]. What they found is that 
although the UHC model demonstrated better performance in the total study population, 
the difference was achieved by reflecting postoperative complications, and therefore the 
predictive discrimination was equivalent to random chance. Thus, it is critical to use a well-
constructed and validated clinical risk model that reflects the patient comorbidities and 
acuity, with high correlation to the endpoints of interest. The next section describes the 
processes by which a robust clinical risk model is developed and validated. 
3.3. Development of a clinical risk model  
The study population is key to the quality and performance of the statistical model, and no 
risk adjustment model is better than the data on which it is based [40]. The population must 
be adequately defined, and exclusion applied for key missing data elements. The population 
is then randomly divided into two samples. The first sample of 60% of the population, 
known as the training sample, is for development of the risk model—used to identify 
predictor variables and estimate model coefficients [46,47,48]. Data from the other 40%, 
known as the test sample, is for the validation of the model, to assess model fit, 
discrimination and calibration. 
The endpoints and outcomes of interest then need to be identified and defined. The nine 
major endpoints of interest for the STS adult cardiac surgery database [46,47,48] are as 
follows:  
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1. operative mortality—defined as death during the same hospitalization as surgery 
regardless of timing, or within 30 days of surgery regardless of venue or site;  
2. permanent stroke or cerebrovascular accident—a central neurologic deficit persisting 
longer than 72 hours; 
3. renal failure—an increase of the serum creatinine to more than 2.0 mg/dL and double 
the most recent preoperative creatinine level, or a new requirement for dialysis; 
4. prolonged requirement of mechanical ventilation support(longer than 24 hours); 
5. deep sternal wound infection—in most recent database versions recorded for as long as 
30 days postoperatively; 
6. reoperation for any reason; 
7. major morbidity or mortality—a composite defined as the occurrence of any of the 
above endpoints; 
8. prolonged postoperative length of stay—length of stay more than 14 days; and 
9. short postoperative length of stay—length of stay less than six days and patient alive at 
discharge. 
The major endpoints for the general thoracic surgery database are selected using similar 
principles, but with appropriate differences of interest to general thoracic surgeons and their 
patients. Adverse outcome measure selection is based on clinical judgment, literature review 
and preliminary data analysis. The postoperative endpoints selected for lung surgery are: 
mortality (in-hospital mortality regardless of timing or within 30 days of the procedure), 
tracheostomy, reintubation, initial ventilator support greater than 48 hours, adult 
respiratory distress syndrome, bronchopleural fistula, pulmonary embolus, pneumonia, 
bleeding requiring reoperation, and myocardial infarction [49,50]. The selected major 
outcomes for esophageal surgery consist of the following conditions: bleeding requiring 
reoperation, anastomotic leak requiring medical or surgical treatment, reintubation, initial 
ventilation greater than 48 hours, pneumonia, or in-hospital mortality (same hospitalization) 
regardless of timing [51].  
The STS Congenital Database Taskforce and the Joint EACTS-STS Congenital Database 
Committee have critically reviewed and defined endpoints as well. Operative mortality is 
again defined as any death, regardless of cause, occurring within 30 days after surgery in or 
out of the hospital and after 30 days during the same hospitalization subsequent to the 
operation [22]. Because of the extensive spectrum of congenital heart defects and the wide 
variety of procedures for same, the complications of interest for the congenital databases are 
also more extensive and detailed, with significant attention to definitions [23,43]. 
All candidate variables are considered, and screened for relevance to prediction at 
population and at individual levels. It is of great value to have expert clinician review as 
well, to assure clinical relevance of the variables to be included. The validity—on its face, as 
well as of construct and content—is key to the value of the risk model, and so it needs to 
make sense to the clinician users. 
The definitions for predictor variables and for endpoints must be strictly standardized. Even 
for an unambiguous endpoint like mortality, the time period and location become important 
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components of the definition. There are important statistical and policy implications of 
using in-hospital mortality (without time limit) versus 30-day all-cause mortality (without 
consideration of where it occurs) versus operative mortality as either of the two. The fixed 
time period is statistically preferable, although more difficult to obtain with completeness 
and accuracy than in-hospital mortality [40]. 
The risk model development team has to assess the database for several aspects of variable 
reporting to determine inclusion or exclusion. The first for consideration is the frequency of 
missing data for each variable. A second consideration is identification of variables that are 
collected inconsistently or with questionable reliability, even for clinically unavoidable 
reasons. Use of derived variables (e.g., body mass index) or redundant variables, such as 
glomerular filtration rate which is a complex function of variables that are consistently and 
regularly included, should be assessed for appropriateness of inclusion in the model. 
Finally, there is consideration of whether to include potentially controversial variables, 
especially those that raise clinical, statistical or health policy issues. Examples of such 
variables include race and ethnicity, and preoperative intra-aortic balloon pump. As a 
confirmatory check, it is helpful to review potential candidate variables against external 
resources, such as previous versions of a risk model, and other comparable risk models 
from other groups or organizations. 
As described by both Clark and by Shahian and colleagues, there are three principal 
techniques that have been utilized for construction of cardiac surgery risk models [40,52]. 
Bayesian models are useful in early database experience as they are robust in the face of 
missing data. Logistic regression models are the most common statistical technique for risk 
modeling—utilized by regional and national databases such as those in New York, the VA, 
and the NNE. Multivariable logistic regression is utilized for the STS national databases. 
Some use simple, additive scores with weights derived from the logistic regression model. 
Shahian and colleagues found that comparative studies have generally demonstrated that 
logistic models offer the best overall performance [40,53,54]. There is interest in the potential 
advance offered by application of algorithmic models, which are also known as machine-
learning techniques, as these models permit complex, nonlinear information processing. 
However, tests of these models have not yet shown significant improvement over logistic or 
Bayesian models [40,55,56]. 
3.4. Risk model validation 
Once the multivariable logistic regression is applied, the test sample of the defined 
population is used to test model performance and to validate the new model against its 
performance for the development sample and against the old model, if an update. The C-
index is assessed for the training or development sample and the test or validation sample, 
looking for close agreement between the two samples for each endpoint. Alternatively, 
calibration can be assessed by plots of observed versus expected event proportions within 
deciles of predicted risk for the various endpoints, such as described by Shahian and 
colleagues [46,47,48]. 
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For each of the STS risk models—CABG surgery, valve surgery, and combined CABG and 
valve—there have been multiple iterative refinements and updates to each. Calibration is 
required after obtaining raw STS risk scores, done annually (in quarterly increments), so that 
the calibration factors are dynamic, updated quarterly after each data harvest [40]. Jin and 
colleagues have reported that if the risk models are used without calibration, the risk scores 
are almost always higher than they should be, overstating risk and understating the 
observed-to-expected ratio [57]. 
Numerous types of validity can be used to scrutinize a statistical risk model. One is face 
validity, where the model is reasonable to experts. A second is content validity, where all 
important variables have been included. A third type is attributional validity, in which risk 
adjustment is adequate to insure that differences in outcome are not due to patient 
characteristics. Finally, there is predictive validity, which provides a measure of how well it 
performs on a data set other than the one from which it is developed, internal or external 
[40]. There are two tests applied to test predictive validity. The first, calibration, assesses 
reliability, or the extent to which the model assigns appropriate risk to the population under 
consideration, the most common of which is the degree of concordance between deciles of 
observed and expected risk, or the Hosmer-Lemeshow test [40]. By extension, and as is 
demonstrated by Tran and colleagues [58] and Zhang and colleagues [59], there is also 
naturally great interest in comparing the risk models against each other, including extension 
into intermediate timeframes (e.g., one-year survival). The second test, discrimination, 
assesses the tradeoff between specificity and sensitivity of the risk model at various 
probability cut points [40,60].  
Following the calculation of the model performance measures, the final regression 
coefficients can then be estimated from the combined training (development) and test 
(validation) samples. The algorithm, intercept and coefficients can then be deployed for the 
risk model, for application for risk prediction for individuals and for population analysis.  
4. Application of risk prediction in decision-making and care 
4.1. Application at the bedside 
Risk prediction tools that are easily accessible and user-friendly are the most valuable for 
application in the clinic or at the bedside. Tools providing calculations as the data are 
entered contribute to clinical decision-making in real-time. The STS provides an on-line risk 
calculator for just such a purpose [61]. It is at the bedside or in the clinic where the 
counseling is being provided, and the patient’s and family’s questions and concerns for risk 
versus benefit and chances for recovery versus adverse outcomes are being actively 
considered. Data-driven decision-making is extremely helpful, especially as applied to 
consideration of the patient preferences and expectations for the care plan and procedure 
being recommended.  
When the patient is high-risk for surgery, the data help convey the statistical chances for 
mortality and adverse outcomes to provide realistic expectations and balance to the hope for 
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a good outcome that can potentially be held out of proportion to the reality of the situation. 
Sometimes this may even take the form of supporting data-driven decision-making to 
recommend against a surgical procedure. A surgeon’s knowing how to do a procedure does 
not automatically obligate the surgeon to operate, nor does it make a procedure right for 
every patient. In other words, it is important to consider when it may be appropriate to say 
‘no,’ but doing so in an objective manner, based on the best available data and evidence. 
When the patient condition and/or the cardiac anatomy is complex, and the 
recommendations by cardiologist and cardiac surgeon are not clearly guided by the 
evidence in the literature, data provided by the risk prediction tool can help provide input 
for shared decision-making by clinicians and patient. This is particularly enhanced by data-
driven risk prediction for medical and surgical therapy, and for proceduralists from both 
medical and surgical subspecialties. 
4.2. Individual performance trends 
The clinician needs an accurate and reliable data source to answer the question, “How am I 
doing?” Practice guidelines, building on the evidence in the literature, provide 
recommendations for the standards of care on which proficient and expert clinicians have 
built consensus. The guidelines, however, do not provide information on the individual 
practitioner’s application of and adherence to the guidelines. It should be noted that 
following guidelines does not absolve the surgeon of applying good judgment for 
extenuating patient needs and circumstances. The guidelines and standards should be 
generally applied, however, and the exceptions and variance should occur rarely. Risk 
models help to assess the trend in decision-making and practice patterns. This is an 
important opportunity to allow the data to tell the story about actual practice patterns, as 
opposed to the good intentions to follow guidelines and apply standard of care. One’s 
perceptions of practice patterns are not always borne out by the data; thus, it is important, 
even imperative, to regularly evaluate oneself for practice-based learning and 
improvement. 
Individual provider decisions on patient selection for operation are important to assess 
against appropriateness guidelines. Variance from recommended indications for operation 
should only be considered as a part of a research study, such as would be employed to 
assess procedure and timing of surgery for lung cancer. 
4.3. Group or hospital performance trends 
The trends in patient selection and provider practice patterns are also assessed for the group 
practice or hospital clinical service—the site of practice—by aggregating the individual 
provider data within the group or hospital practice. Within a group of providers there may 
be varying degrees of experience, and providers may be at different points along the lifelong 
learning curve of evolution from competence to proficiency to expertise and mastery. 
However, the clinical pathways by which the care is delivered offer an opportunity for 
setting the expected logistics for delivery of care in the perioperative cardiothoracic surgery 
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patient. The risk-adjusted data provided as feedback to the group help the group to assess 
the impact of the processes and decision-making strategies commonly employed. 
Although hospital and/or provider case volume have long been used as a proxy measure for 
quality, it is important to note that data show only modest association of hospital procedural 
volume with CABG outcomes [62]. Thus, volume may not be an adequate quality metric for 
CABG surgery. Database participation allows for demonstration of where low-volume 
providers and hospitals achieve high quality outcomes, and where high-volume providers 
and hospitals do not.  
Assessing patient referral and selection trends for the group or hospital against 
appropriateness guidelines further allow objective data-driven feedback. A new cardiac or 
thoracic surgery program may be perceived to get good outcomes because it is too 
conservative in patient selection for surgery—by “cherry-picking” cases to enhance 
outcomes. Alternatively, a new cardiac or thoracic surgery program may wish to build 
volume and be or become too liberal in its patient selection for surgery. Database feedback 
provides valuable perspective against which to weigh public perspective—among the 
provider and the general community—based on data and the appropriateness guidelines.  
5. Performance data for reporting and improvement 
5.1. Performance data types 
There are two primary types of performance data—process measures and outcome 
measures. A process measure reflects how an aspect of care is delivered. An outcome 
measure reflects the impact of care on the patient—or how the patient does as a result of the 
processes of care.  
5.2. Process measures 
Process measures may be captured as timed intervals, as exemplified by the time interval 
between myocardial infarction and operation, time on cardiopulmonary bypass, cross-clamp 
time, time interval for mechanical ventilation (or time to extubation), length of stay in the 
ICU and postoperative length of stay. Other process measures are reflected as counts, such 
as lowest hematocrit on bypass and number of blood products transfused. A third type of 
process measure is reported as a yes/no response, as in the reporting of use of the internal 
mammary (or thoracic) artery (IMA) as bypass conduit, use of cardiopulmonary bypass 
(versus off-pump), or use of recommended medications at discharge, specifically aspirin, 
beta blockade, and cholesterol-lowering statin therapy. 
Preoperative process measures include time from presentation with myocardial infarction to 
operation, use of intra-aortic balloon pump, preoperative creatinine, and administration of 
preoperative beta blockade. In general thoracic, preoperative process measures include 
administration of induction chemotherapy, and urgent versus elective procedure status. 
Intraoperative process measures in cardiac surgery include use of cardiopulmonary bypass 
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versus off-pump surgery, use of the left IMA as a conduit for bypass, and perioperative 
transfusion. General thoracic intraoperative process measures include thoracotomy versus 
video-assisted thoracoscopic surgery, and procedure selection (extent of resection versus 
wedge resection). These measures are important in the assessment of patient selection and 
management prior to operation, as related to risk prediction for postoperative outcomes.  
Postoperative process measures for cardiac surgery include administration of blood 
transfusion and discharge medication regimen (antiplatelet med such as aspirin, beta 
blockade, and statin). Hospital postoperative length of stay, discharge destination and 
readmission are of increasing importance in assessing care coordination for optimal 
outcomes. 
5.3. Outcome measures 
As noted above in relation to development of risk prediction models, it is key to identify 
endpoints of interest for the database users, providers and patients. Obviously, it is impossible 
for a database to capture every conceivable outcome, but there is consensus on major adverse 
events for which the database or registry can provide a robust and valuable resource.  
The most familiar outcome measure, of course, is mortality rate. Mortality can be reported 
as a raw mortality rate—a count of deaths per the patient or case denominator, or as a 
comparison ratio of the observed mortality rate over the expected or predicted mortality 
rate. Furthermore, in the section above on risk model endpoints, the various definitions for 
mortality consideration were reviewed. But why is there so much detail to be worked out 
around such an unambiguous endpoint of mortality (living versus dead is usually thought 
of as an easy distinction to determine), and what does it mean to the provider and/or 
organization? Is the surgery any more successful if the patient gets out of the hospital alive, 
but dies at home? What is the impact to the patient versus the provider and/or hospital if the 
patient dies on the 31st day after surgery instead of sooner? And why is it important to 
capture all-cause mortality versus cardiac or thoracic surgery-specific causes? As an 
example, all-cause mortality means that death from a bowel obstruction during the same 
hospitalization as the cardiothoracic procedure would count as in-hospital or operative 
mortality for the cardiac surgeon. Questions like these are what engage the concerted efforts 
of the taskforces and expert panels that work to build consensus on the definitions for their 
databases and the performance reporting from those databases. 
Major morbidities, or non-fatal adverse outcomes, commonly reported in cardiac surgery 
are represented by rates for unplanned reoperation (usually for postoperative hemorrhage), 
prolonged ventilator support requirement (>24 hours), cerebrovascular accident or new 
neurologic defect, new renal insufficiency or renal failure, deep sternal wound infection, 
prolonged length of stay (>7 days). Readmission within 30 days is of growing importance as 
providers and payers assess quality across the continuum of care, and not just around the 
in-hospital procedural event.  
Major morbidity in general thoracic surgery includes pneumonia, adult respiratory distress 
syndrome, empyema, sepsis, bronchopleural fistula, pulmonary embolism, ventilator 
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support beyond 48 hours, reintubation, tracheostomy, atrial or ventricular arrhythmias 
requiring treatment, myocardial infarction, reoperation for bleeding, and central neurologic 
event. 
There is one additional way of thinking about outcomes. This is as a standardized incidence 
ratio for the composite outcome of any adverse outcome—any mortality or major morbidity. 
This allows for discussion and counseling that takes into consideration the collective impact 
of multiple risk factors and comorbidities on successful, uncomplicated recovery and return 
to quality of life. 
5.4. Application of performance measures for reporting quality 
Those databases with mandatory participation, such as the New York and Pennsylvania 
databases and the VA database described previously, provide regular reports, usually on an 
annual basis. Voluntary databases, such as NNE and STS, also provide regular reports to 
participants, although on a more frequent interval.  
 One of the uses of the regular reporting is to provide the individual and group with their 
own performance results. A second is to place those results in the context of national 
normative data. This allows the individual and group to assess their practice patterns 
against not only the guidelines and evidence in the literature, but against other practicing 
physicians in the specialty as a whole.  
Process prevalence and variability can be studied and reported to advance the practice of 
cardiothoracic surgery. One example is provided by Tabata and colleagues regarding the 
use of the IMA graft in multivessel CABG surgery [63]. Since use of the IMA graft has been 
repeatedly shown to be associated with significantly improved short-term and long-term 
survival in CABG, it is encouraging to see the frequency of IMA use in CABG surgery to be 
increasing. However Tabata’s study shows that many patients do not receive the benefits of 
IMA grafts, and some hospitals have a very low IMA use rate, which offers a significant 
opportunity for continued improvement [63]. 
The STS database, as with other databases such as the NNE, has been the source of data for 
numerous studies on risk factors and association with outcomes. Studies have been done on 
relationship to outcomes of gender, race, obesity, diabetes, age, renal function, off-pump 
CABG, and emergency CABG, as examples [64]. Risk profiles and outcomes can be studied 
by procedure, as has been done with CABG trends over time as shown by Ferguson and 
colleagues [65] and ElBardissi and colleagues [66], and with 15-year valve surgery outcome 
trends as has been done by Lee and colleagues [67]. Risk factors and outcomes, especially 
mortality, can be studied by region, to assess outcomes in an effort to identify regional best 
practices and to spread improvements in cardiac surgical outcomes [68].  
In addition to providing reports that allow individuals and groups to compare with their 
peers, regionally and nationally, cardiothoracic surgery databases can also be compared 
with each other, to compare patient populations and assess the quality of their reports 
relative to one another. One example of such a study has been provided by Grover and 
 
Risk Prediction and Outcome Analysis 79 
colleagues, comparing the VA and STS cardiac surgery databases [69]. Grover’s findings 
were that, in spite of the major difference in the male proportion of patients between the two 
databases, risk factors are otherwise very similar. Moreover, both databases have shown a 
significant reduction in the risk-adjusted operative mortality rate over a decade of provide 
risk-adjusted performance to their participants, with observed-to-expected death ratios 
decreasing from 1.05 to 0.9 in the VA system, and 1.5 to 0.9 for the STS participants. This 
reinforces the conclusion that the availability of data reports for practice-based learning and 
improvement is thus shown to improve care and outcomes for patients. 
As previously noted, procedure volume has long been associated with quality outcomes. 
Database reports on outcomes have prompted studies of procedure volume in comparison 
with clinical quality measures—mortality, morbidity, and processes of care [70]. For a 
voluntary database, critics have expressed concern that not having full participation can 
potentially skew the data, and thus, the outcomes. In this case the comparison of outcomes 
against the higher volume in a larger database (e.g., Medicare), can help to reinforce the 
accuracy of the quality of the data reported [71].  
The quality measurements in adult cardiac surgery have been applied to develop a 
methodology for comprehensive assessment of adult cardiac surgery quality of care, 
including both individual measures and an overall composite quality score. A Cardiac 
Surgery Performance Measures Steering Committee and the associated Technical Advisory 
Panel convened by the National Quality Forum (NQF) selected a set of 21 structure, process, 
and outcomes measures to assess quality of cardiac surgery care in the US. Incorporating the 
trend in health care quality assessment for the use of bundled measures and “all-or-none” 
scoring, the STS Quality Management Taskforce (QMTF) chose eleven individual quality 
measures grouped within four domains that included all relevant CABG process and 
outcomes measures endorsed by the NQF. The four domains of STS quality measures are 1) 
perioperative medical care of preoperative beta blockade, discharge aspirin, discharge beta 
blockade, and discharge antilipid therapy; 2) operative care of the use of at least one IMA; 3) 
risk-adjusted operative mortality; and 4) absence of postoperative morbidity, specifically 
renal insufficiency, deep sternal wound infection, re-exploration for any cause, stroke, and 
prolonged ventilation/intubation [72]. The STS QMTF has developed and tested a composite 
measure of cardiac surgery quality that encompasses multiple domains of care, uses 
Bayesian random-effects analyses, uses all-or-none scoring where appropriate, and avoids 
subjective weighting of individual measures, to provide validated quality measures useful 
to various types of users [73]. With the STS composite quality score in use, Shahian and 
colleagues looked at the association of hospital CABG volume to the STS composite quality 
score, and found only 1% of composite score variation was explained by volume [70]. 
5.5. Application of performance measures for improving quality 
With the data reports described above, data becomes information provided for self-
examination and self-assessment, which in turn can be the starting point for improving 
quality and outcomes. The individual and group reports have prompted the response of, 
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“What does this mean?...and what can I do to improve it?” This is the start of the necessary 
self-examination and self-reflection, followed by system examination, on which to build the 
quality improvement. When the data is shared with the other members of the 
interdisciplinary team, it is even more powerful, as it prompts self-assessment and drives 
buy-in for a collaborative approach to improvement. Carefully designed and disciplined 
teamwork and reliable implementation of evidence-based protocols applied by an 
empowered front line helps make improvements, especially decreasing complications and 
increasing cost savings [74]. 
6. Database use across the continuum of care 
6.1. Linkage of databases 
The STS database, as a national voluntary participation database, has seen growing 
participation, especially over recent years. However, it has still been important to quantify 
the completeness of the STS database as representative of cardiac surgery care in the US. To 
that end, the STS linked successfully with the Centers for Medicare and Medicaid Services 
(CMS) Medicare database and demonstrated high and increasing penetration and 
completeness of the STS database [75]. In addition, this linkage should facilitate studying 
long-term outcomes of cardiothoracic surgery. The STS Congenital Heart Surgery database 
has also performed successful linkage to the Pediatric Health Information System database, 
an administrative database. This will similarly allow providers to conduct database research 
that capitalizes on the enhancements provided by linking both types of data to answer 
important clinical questions [76]. 
It has been noted repeatedly in this discussion that the surgical databases have focused on 
short-term outcomes, with mortality being captured as in-hospital or 30 days. But what can we 
learn about how the patients are doing after 30 days? What data sources may be available to 
the provider, beyond personal provider or staff follow-up with the patient and/or his/her 
primary physician? The NNE has linked that database to the National Death Index, to provide 
long-term survival outcomes [77]. In the interest of more complete and accurate objective data, 
the STS has linked to the Social Security Death Master File, which allows for verification of 
“life status.” This successful linkage of the STS database to social security data has allowed 
examination of survival after cardiac operations—CABG, aortic valve replacement and mitral 
valve operations—with initial reporting on one-year survival [78].  
In an important study looking at long-term outcomes, the STS, the American College of 
Cardiology Foundation, and the Duke Clinical Research Institute are collaborating on a 
comparative effectiveness study (American College of Cardiology Foundation—Society of 
Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization 
Strategies [ASCERT]) of CABG and percutaneous coronary interventions (PCI). This study 
has developed a long-term mortality (or survival) risk prediction model for CABG and PCI, 
i.e., considering outcomes across the continuum of care [79]. In another early report on 
comparative effectiveness of revascularization strategies, Weintraub and colleagues have 
found that, among older patients with multivessel coronary artery disease not requiring 
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emergency treatment, there was a long-term survival advantage among patients who 
underwent CABG as compared to patients who underwent PCI [80]. Studies like this will 
continue to inform providers as they improve shared decision-making and quality, using 
the data-driven comparative effectiveness research. 
6.2. Future opportunities for database improvement 
Databases have been firmly established as sources of data for driving learning and 
improvement. Providers who participate in clinical registries or databases are therefore 
facilitating their own individual and collective practice-based learning and improvement. 
The variables captured in these databases will continue to be improved—by building 
evidence-based consensus on definitions, and by addition of variables needed to more 
completely represent the patients. In the risk factor discussion above, it was mentioned that 
there are aspects of patient condition that are not currently captured—including poor 
nutritional status and homelessness. Also discussed under risk factors was the challenge of 
capturing rehabilitation potential, relative to anticipated quality of life goal following 
postoperative recovery. It should be noted that Afilalo and colleagues have proposed using 
an integrative approach combining frailty, disability, and STS risk scores to better 
characterize elderly patients referred for cardiac surgery, and especially to identify those at 
increased risk [81].  
While there is benefit in enhancing the databases by adding or refining variables where 
appropriate, it will remain imperative to exercise excellent quality control of data entered 
into the database, especially by applying consistent standardized definitions [82]. As the 
electronic medical record becomes more pervasive in the US and elsewhere, this process 
may become more streamlined, but it will remain important to conduct appropriate audits 
for completeness and accuracy of data to decrease variability that would make the data and 
derived calculations suspect. 
In the spirit of Dr. Codman, who in 1917 called for hospitals to release and compare 
outcomes data [2], the STS has initiated voluntary public reporting of database participant 
performance [83]. The rationale is to provide transparency and promote accountability. With 
implementation, will follow the continued need for appropriate auditing and reporting of 
composite measures using credible data and methodologies, thus decreasing the likelihood 
of other entities developing measures from inferior methodologies which use unadjusted or 
inadequately adjusted administrative data [83,84]. 
7. Conclusion 
A complete and accurate database is essential in order to provide vital information to 
patients, to providers, and to society. The patient needs valid and accurate prediction 
derived from data on procedural risk to aid in decision-making and to set realistic 
expectations for outcomes of care. The provider needs a valid and accurate risk prediction 
tool with which to appropriately counsel patients, families and colleagues. The provider 
needs valid and trusted reports on process and outcome measures in order to carry out 
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appropriate and necessary assessment of self and system by which to improve. The public 
needs to see that the providers and the profession are measuring and monitoring, and using 
data for improvement of decision-making and care delivery, to ensure safe, timely, effective 
care. Cardiothoracic surgeons have been leaders in database development and testing, but 
even stronger leaders in applying the data to improve practice and outcomes for patients. 
This is a critical role and responsibility, but also an opportunity to make an invaluable 
contribution to our patients. 
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